Strategic Partnerships Pharmazz has established collaboration with Sun Pharmaceutical and Dr. Reddy's Laboratories to market Centhaquine and Sovateltide in India, presenting clear cross-sell and co-marketing opportunities with large, established distributors and access to Indian healthcare networks.

India Market Action Marketing authorizations in India for Centhaquine and Sovateltide create a ready-licensing and distribution opportunity for regional sales teams to expand into critical care products with proven first-in-class potential.

Finance Backing Recent $25M strategic equity from Sun Pharma and overall funding of $38M provide validating capital for joint go-to-market programs, manufacturing scaling, and accelerated clinical or regulatory efforts in target markets.

Key Leadership New CFO Ajay Bansal and President Neil Marwah strengthen finance and strategic execution, supporting structured sales planning, pricing strategies, and international expansion initiatives.

Portfolio Fit Two approved Phase III INDs and two marketed first-in-class molecules position Pharmazz as a source for high-value resuscitative and neurovascular therapies, enabling targeting of large hospital networks, critical care units, and stroke treatment pathways.